BRCA1
Another Legal Setback for Myriad
Another Legal Setback for Myriad
Kerry Grens | Mar 11, 2014
A judge declines Myriad Genetics’s request to block its competitors from selling BRCA tests.  
Speaking of Science
Speaking of Science
The Scientist Staff | Aug 1, 2013
August 2013's selection of notable quotes
Another Lawsuit over Genetic Tests
Another Lawsuit over Genetic Tests
Kate Yandell | Jul 11, 2013
Myriad Genetics, the company originally behind tests for the cancer-associated BRCA mutations, is suing two competitors for patent infringement.
Gene Patents Decision: Everybody Wins
Gene Patents Decision: Everybody Wins
Jeffrey M. Perkel | Jun 18, 2013
Last week’s Supreme Court decision to invalidate patents on human genes was a win for patients, independent researchers, and even the wider biotech industry.
Supreme Court Nixes Patenting Human Genes
Supreme Court Nixes Patenting Human Genes
Dan Cossins | Jun 13, 2013
The Justices have decided that isolated sequences of human DNA are not eligible for patent protection, but rules that artificial sequences can be patented.
 
Why Women’s Eggs Don’t Last
Why Women’s Eggs Don’t Last
Kate Yandell | Feb 13, 2013
As reproductive tissues age, DNA repair mechanisms become less efficient, causing genomic damage to accumulate.
Should Human Genes be Patented?
Should Human Genes be Patented?
Edyta Zielinska | Dec 3, 2012
The Supreme Court agrees to hear a case deciding if two cancer genes should continue to be protected by patent.
Court Rules Gene Patents Valid
Cristina Luiggi | Aug 17, 2012
Myriad Genetics can hold patents on the BRAC1 and BRAC2 oncogenes, but not on tests comparing DNA sequences.
Gene Patents Back in Court
Cristina Luiggi | Jun 19, 2012
A public interest legal group has renewed the fight against DNA patenting.
Finding Phenotypes
Edyta Zielinska | Apr 1, 2012
Genes shared across species that produce different phenotypes – deafness in humans and directional growth in plants – may reveal new models of disease.